Year: 2023

Topos_Akron-Bio_Logo_Full-Color_Lockup-C_28129-1

Akron Bio Receives Eligibility Confirmation from PMDA in Japan for the Commercialization of Virus Inactivated Human Fibronectin in Clinical Cell Therapy Manufacturing

BOCA RATON, Fla.--(BUSINESS WIRE)--Akron Bio (“Akron”), a leading supplier of critical inputs for cell and gene therapies, today announced that...

Topos_Akron-Bio_Logo_Full-Color_Lockup-C_28129

Akron Bio Receives Eligibility Confirmation from PMDA in Japan for the Commercialization of Virus Inactivated Human Fibronectin in Clinical Cell Therapy Manufacturing

BOCA RATON, Fla.--(BUSINESS WIRE)--Akron Bio (“Akron”), a leading supplier of critical inputs for cell and gene therapies, today announced that...

Critical_Metals_Corp_-_Final_01

Critical Metals Corp. Announces MoU between European Lithium Ltd and Obeikan Investment Group to Build and Operate Hydroxide Plant in Saudi Arabia

50:50 joint venture for hydroxide plant is expected to generate significant savings for Critical Metals Corp.’s Wolfsberg Project PERTH, Australia...